HIMS · Hims & Hers Health, Inc.
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
Insider Sentiment Score
Peer-relative 0–100 rank of how aggressively insiders accumulated over the trailing 90 days. See the full ranking.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-07-17 | Okupe Oluyemi |
Chief Financial Officer |
Sell↓
Filing footnotes — Class A Common Stock (Direct)
The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person. Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $31.93 - $32.06. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
Class A Common Stock
|
7,163 |
| 2026-07-17 | Okupe Oluyemi |
Chief Financial Officer |
Convert↑
Filing footnotes — Class A Common Stock (Direct)
The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person. |
Class A Common Stock
|
7,163 |
| 2026-07-17 | Okupe Oluyemi |
Chief Financial Officer |
Convert↓
Filing footnotes — Stock Option (right to buy) (Direct)
The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person. 25% of the options will vest on the twelve (12) month anniversary of the Vesting Commencement Date of January 24, 2022. The balance of the shares shall vest in a series of thirty-six (36) successive equal monthly installments measured from the twelve (12) month anniversary of the Vesting Commencement Date, subject to optionholder's continuous Service (as defined in the Plan) as of each such vesting date. |
Stock Option (right to buy)
|
7,163 |
| 2026-07-06 | Okupe Oluyemi |
Chief Financial Officer |
Sell↓
Filing footnotes — Class A Common Stock (Direct)
The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person. Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $36.35 - $36.70. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
Class A Common Stock
|
7,163 |
| 2026-07-06 | Okupe Oluyemi |
Chief Financial Officer |
Convert↓
Filing footnotes — Stock Option (right to buy) (Direct)
The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person. 25% of the options will vest on the twelve (12) month anniversary of the Vesting Commencement Date of January 24, 2022. The balance of the shares shall vest in a series of thirty-six (36) successive equal monthly installments measured from the twelve (12) month anniversary of the Vesting Commencement Date, subject to optionholder's continuous Service (as defined in the Plan) as of each such vesting date. |
Stock Option (right to buy)
|
7,163 |
| 2026-07-06 | Okupe Oluyemi |
Chief Financial Officer |
Convert↑
Filing footnotes — Class A Common Stock (Direct)
The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person. |
Class A Common Stock
|
7,163 |
| 2026-06-22 | Okupe Oluyemi |
Chief Financial Officer |
Sell↓
Filing footnotes — Class A Common Stock (Direct)
The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person. Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $33.65 - $34.57. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
Class A Common Stock
|
18,197 |
| 2026-06-22 | Okupe Oluyemi |
Chief Financial Officer |
Convert↓
Filing footnotes — Stock Option (right to buy) (Direct)
The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person. 25% of the options will vest on the twelve (12) month anniversary of the Vesting Commencement Date of January 24, 2022. The balance of the shares shall vest in a series of thirty-six (36) successive equal monthly installments measured from the twelve (12) month anniversary of the Vesting Commencement Date, subject to optionholder's continuous Service (as defined in the Plan) as of each such vesting date. |
Stock Option (right to buy)
|
6,376 |
| 2026-06-22 | Okupe Oluyemi |
Chief Financial Officer |
Convert↑
Filing footnotes — Class A Common Stock (Direct)
The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person. |
Class A Common Stock
|
6,376 |
| 2026-06-18 | Carroll Patrick Harrison |
Director, Chief Medical Officer |
Sell↓
|
Class A Common Stock
|
23,726 |
| 2026-06-17 | Elshenawy Mohamed |
Director |
Sell↓
Filing footnotes — Class A Common Stock (Direct)
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 1, 2025 by the Reporting Person. |
Class A Common Stock
|
30,040 |
| 2026-06-17 | Becklund Irene |
PAO |
Sell↓
Filing footnotes — Class A Common Stock (Direct)
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 5, 2025 by the Reporting Person. |
Class A Common Stock
|
4,490 |
| 2026-06-17 | Chi Michael |
Chief Operating Officer |
Sell↓
Filing footnotes — Class A Common Stock (Direct)
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 1, 2025 by the Reporting Person. |
Class A Common Stock
|
14,027 |
| 2026-06-16 | Becklund Irene |
PAO |
Sell↓
Filing footnotes — Class A Common Stock (Direct)
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 5, 2025 by the Reporting Person. |
Class A Common Stock
|
7,573 |
| 2026-06-15 | Payne Christopher D |
Director |
Convert↑
Filing footnotes — Class A Common Stock (Direct)
The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 3-year period, with : (i) 1/3 of the RSUs vesting on June 15, 2025, (ii) 1/3 of the RSUs vesting on June 15, 2026, and (iii) 1/3 of the RSUs vesting on May 15, 2027. |
Class A Common Stock
|
10,040 |
| 2026-06-15 | Elshenawy Mohamed |
Director |
Tax↓
Filing footnotes — Class A Common Stock (Direct)
The shares of Class A Common Stock were withheld by the issuer to cover tax withholding obligations in connection with the reported vesting and settlement of RSUs. |
Class A Common Stock
|
151,534 |
| 2026-06-15 | Carroll Patrick Harrison |
Director, Chief Medical Officer |
Convert↑
Filing footnotes — Class A Common Stock (Direct)
The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. |
Class A Common Stock
|
25,926 |
| 2026-06-15 | Elshenawy Mohamed |
Director |
Convert↑
Filing footnotes — Class A Common Stock (Direct)
The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. |
Class A Common Stock
|
282,597 |
| 2026-06-15 | Carroll Patrick Harrison |
Director, Chief Medical Officer |
Convert↓
Filing footnotes — Restricted Stock Unit (Direct)
The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the Company's quarterly vesting dates, with the first such vesting date on June 15, 2024. |
Restricted Stock Unit
|
4,840 |
| 2026-06-15 | Carroll Patrick Harrison |
Director, Chief Medical Officer |
Convert↓
Filing footnotes — Restricted Stock Unit (Direct)
The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the Company's quarterly vesting dates, with the first such vesting date on June 15, 2025. |
Restricted Stock Unit
|
3,533 |
| 2026-06-15 | Dudum Andrew |
Director, Chief Executive Officer, 10% Owner |
Convert↑
Filing footnotes — Class A Common Stock (Direct)
The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. |
Class A Common Stock
|
154,991 |
| 2026-06-15 | Okupe Oluyemi |
Chief Financial Officer |
Convert↓
Filing footnotes — Restricted Stock Unit (Direct)
The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the Company's quarterly vesting dates, with the first such vesting date on June 15, 2024. |
Restricted Stock Unit
|
22,988 |
| 2026-06-15 | WELLS DAVID B |
Director |
Convert↑
Filing footnotes — Class A Common Stock (Direct)
The RSUs were issued to the Reporting Person pursuant to the Issuer's Director Compensation Policy, in lieu of the director retainer and committee membership fees for the first quarter of 2026. The number of RSUs granted was calculated by dividing the foregone cash fees of $22,000 by the grant price of $22.98. The RSUs will vest in full on the Company's next quarterly vesting date. |
Class A Common Stock
|
957 |
| 2026-06-15 | Okupe Oluyemi |
Chief Financial Officer |
Convert↑
Filing footnotes — Class A Common Stock (Direct)
The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. Includes 1,113 shares acquired on May 20, 2026, under the Hims & Hers Health, Inc. 2020 Employee Stock Purchase Plan. |
Class A Common Stock
|
71,616 |
| 2026-06-15 | Chi Michael |
Chief Operating Officer |
Convert↑
Filing footnotes — Class A Common Stock (Direct)
The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. Includes 304 shares acquired on May 20, 2026, under the Hims & Hers Health, Inc. 2020 Employee Stock Purchase Plan. |
Class A Common Stock
|
86,264 |
| 2026-06-15 | Dudum Andrew |
Director, Chief Executive Officer, 10% Owner |
Tax↓
Filing footnotes — Class A Common Stock (Direct)
The shares of Class A Common Stock were withheld by the issuer to cover tax withholding obligations in connection with the reported vesting and settlement of RSUs. |
Class A Common Stock
|
85,632 |
| 2026-06-15 | Payne Christopher D |
Director |
Convert↓
Filing footnotes — Restricted Stock Unit (Direct)
The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs were issued to the Reporting Person pursuant to the Issuer's Director Compensation Policy, in lieu of the director retainer and committee membership fees for the first quarter of 2026. The number of RSUs granted was calculated by dividing the foregone cash fees of $14,875 by the grant price of $22.98. The RSUs will vest in full on the Company's next quarterly vesting date. |
Restricted Stock Unit
|
647 |
| 2026-06-15 | Chi Michael |
Chief Operating Officer |
Convert↓
Filing footnotes — Restricted Stock Unit (Direct)
The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the Company's quarterly vesting dates, with the first such vesting date on June 15, 2025. |
Restricted Stock Unit
|
10,599 |
| 2026-06-15 | Payne Christopher D |
Director |
Convert↓
Filing footnotes — Restricted Stock Unit (Direct)
The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 3-year period, with : (i) 1/3 of the RSUs vesting on June 15, 2025, (ii) 1/3 of the RSUs vesting on June 15, 2026, and (iii) 1/3 of the RSUs vesting on May 15, 2027. |
Restricted Stock Unit
|
10,040 |
| 2026-06-15 | Autor Deborah M. |
Director |
Convert↑
Filing footnotes — Class A Common Stock (Direct)
The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. |
Class A Common Stock
|
32,919 |
| 2026-06-15 | Becklund Irene |
PAO |
Convert↓
Filing footnotes — Restricted Stock Unit (Direct)
The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the Company's quarterly vesting dates, with the first such vesting date on June 15, 2024. |
Restricted Stock Unit
|
4,344 |
| 2026-06-15 | Elshenawy Mohamed |
Director |
Convert↓
Filing footnotes — Restricted Stock Unit (Direct)
The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the Company's quarterly vesting dates, with the first such vesting date on June 15, 2026. |
Restricted Stock Unit
|
23,513 |
| 2026-06-15 | Chi Michael |
Chief Operating Officer |
Convert↓
Filing footnotes — Restricted Stock Unit (Direct)
The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the Company's quarterly vesting dates, with the first such vesting date on June 15, 2024. |
Restricted Stock Unit
|
19,358 |
| 2026-06-15 | Carroll Patrick Harrison |
Director, Chief Medical Officer |
Convert↓
Filing footnotes — Restricted Stock Unit (Direct)
The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the Company's quarterly vesting dates, with the first such vesting date on June 15, 2026. |
Restricted Stock Unit
|
9,405 |
| 2026-06-15 | Dudum Andrew |
Director, Chief Executive Officer, 10% Owner |
Convert↓
Filing footnotes — Restricted Stock Unit (Direct)
The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the Company's quarterly vesting dates, with the first such vesting date on June 15, 2026. |
Restricted Stock Unit
|
25,865 |
| 2026-06-15 | Boughton Soleil |
Chief Legal Officer |
Convert↓
Filing footnotes — Restricted Stock Unit (Direct)
The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the Company's quarterly vesting dates, with the first such vesting date on June 15, 2024. |
Restricted Stock Unit
|
12,099 |
| 2026-06-15 | Dudum Andrew |
Director, Chief Executive Officer, 10% Owner |
Convert↓
Filing footnotes — Restricted Stock Unit (Direct)
The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the Company's quarterly vesting dates, with the first such vesting date on June 15, 2023. |
Restricted Stock Unit
|
35,446 |
| 2026-06-15 | Carroll Patrick Harrison |
Director, Chief Medical Officer |
Convert↓
Filing footnotes — Restricted Stock Unit (Direct)
The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs were issued to the Reporting Person pursuant to the Issuer's Director Compensation Policy, in lieu of the director retainer fee for the first quarter of 2026. The number of RSUs granted was calculated by dividing the foregone cash fees of $10,000 by the grant price of $22.98. The RSUs will vest in full on the Company's next quarterly vesting date. |
Restricted Stock Unit
|
435 |
| 2026-06-15 | Okupe Oluyemi |
Chief Financial Officer |
Tax↓
Filing footnotes — Class A Common Stock (Direct)
The shares of Class A Common Stock were withheld by the issuer to cover tax withholding obligations in connection with the reported vesting and settlement of RSUs. |
Class A Common Stock
|
39,541 |
| 2026-06-15 | Becklund Irene |
PAO |
Convert↑
Filing footnotes — Class A Common Stock (Direct)
The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. |
Class A Common Stock
|
15,971 |
| 2026-06-15 | Becklund Irene |
PAO |
Tax↓
Filing footnotes — Class A Common Stock (Direct)
The shares of Class A Common Stock were withheld by the issuer to cover tax withholding obligations in connection with the reported vesting and settlement of RSUs. |
Class A Common Stock
|
5,870 |
| 2026-06-15 | Manuel Anja |
Director |
Convert↓
Filing footnotes — Restricted Stock Unit (Direct)
The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 3-year period, with : (i) 1/3 of the RSUs vesting on June 15, 2025, (ii) 1/3 of the RSUs vesting on June 15, 2026, and (iii) 1/3 of the RSUs vesting on May 15, 2027. |
Restricted Stock Unit
|
10,040 |
| 2026-06-15 | Chi Michael |
Chief Operating Officer |
Convert↓
Filing footnotes — Restricted Stock Unit (Direct)
The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the Company's quarterly vesting dates, with the first such vesting date on June 15, 2023. |
Restricted Stock Unit
|
16,297 |
| 2026-06-15 | Becklund Irene |
PAO |
Convert↓
Filing footnotes — Restricted Stock Unit (Direct)
The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the Company's quarterly vesting dates, with the first such vesting date on June 15, 2023. |
Restricted Stock Unit
|
4,065 |
| 2026-06-15 | Carroll Patrick Harrison |
Director, Chief Medical Officer |
Convert↑
Filing footnotes — Class A Common Stock (Direct)
The RSUs were issued to the Reporting Person pursuant to the Issuer's Director Compensation Policy, in lieu of the director retainer fee for the first quarter of 2026. The number of RSUs granted was calculated by dividing the foregone cash fees of $10,000 by the grant price of $22.98. The RSUs will vest in full on the Company's next quarterly vesting date. |
Class A Common Stock
|
435 |
| 2026-06-15 | Dudum Andrew |
Director, Chief Executive Officer, 10% Owner |
Convert↓
Filing footnotes — Restricted Stock Unit (Direct)
The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the Company's quarterly vesting dates, with the first such vesting date on June 15, 2025. |
Restricted Stock Unit
|
19,150 |
| 2026-06-15 | Boughton Soleil |
Chief Legal Officer |
Convert↓
Filing footnotes — Restricted Stock Unit (Direct)
The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the Company's quarterly vesting dates, with the first such vesting date on June 15, 2025. |
Restricted Stock Unit
|
6,183 |
| 2026-06-15 | Chi Michael |
Chief Operating Officer |
Convert↓
Filing footnotes — Restricted Stock Unit (Direct)
The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the Company's quarterly vesting dates occurring on or after December 15, 2022. |
Restricted Stock Unit
|
16,496 |
| 2026-06-15 | Carroll Patrick Harrison |
Director, Chief Medical Officer |
Convert↓
Filing footnotes — Restricted Stock Unit (Direct)
The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 25% of the RSUs vesting on December 15, 2023, and the remaining 75% of the RSUs vesting in substantially equal quarterly installments over the following 3 years, on the Company's quarterly vesting dates occurring thereafter. |
Restricted Stock Unit
|
8,148 |
| 2026-06-15 | Becklund Irene |
PAO |
Convert↓
Filing footnotes — Restricted Stock Unit (Direct)
The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the Company's quarterly vesting dates, with the first such vesting date on June 15, 2025. |
Restricted Stock Unit
|
1,392 |